Epidermal growth factor receptor expression is a candidate target of the synergistic combination of trastuzumab and flavopiridol in breast cancer. (Q42163064)
Jump to navigation
Jump to search
scientific article published on July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epidermal growth factor receptor expression is a candidate target of the synergistic combination of trastuzumab and flavopiridol in breast cancer. |
scientific article published on July 2003 |
Statements
Epidermal growth factor receptor expression is a candidate target of the synergistic combination of trastuzumab and flavopiridol in breast cancer (English)
Rita Nahta
Sally Trent
Chuanwei Yang
Emmett V Schmidt